Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Operating Leases (2021 - 2025)

Zymeworks' Operating Leases history spans 2 years, with the latest figure at $23.5 million for Q2 2023.

  • For Q2 2023, Operating Leases changed N/A year-over-year to $23.5 million; the TTM value through Jun 2023 reached $23.5 million, changed N/A, while the annual FY2022 figure was $24.7 million, N/A changed from the prior year.
  • Operating Leases for Q2 2023 was $23.5 million at Zymeworks, down from $27.4 million in the prior quarter.
  • Across five years, Operating Leases topped out at $27.4 million in Q1 2023 and bottomed at $23.5 million in Q2 2023.